methylphenidate

(redirected from Quillivant XR)
Also found in: Thesaurus, Medical.

meth·yl·phen·i·date

 (mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
n.
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.

[methyl + phen(yl) + (piper)id(ine) + (acet)ate.]

methylphenidate

(ˌmɛθɪlˈfɛnɪˌdeɪt; ˌmɛθɪlˈfiːnɪˌdeɪt)
n
(Pharmacology) a drug that stimulates the central nervous system and is used, in the form of its hydrochloride, to treat narcolepsy as well as attention deficit disorder

meth•yl•phen•i•date

(ˌmɛθ əlˈfɛn ɪˌdeɪt, -ˈfi nɪ-)

n.
a central nervous system stimulant, C14H19NO2, used in the control of hyperkinetic syndromes and narcolepsy.
[1955–60; methyl + phen- + -ide + -ate2]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.methylphenidate - central nervous system stimulant (trade name Ritalin) used in the treatment of narcolepsy in adults and attention deficit disorder in childrenmethylphenidate - central nervous system stimulant (trade name Ritalin) used in the treatment of narcolepsy in adults and attention deficit disorder in children
excitant, stimulant drug, stimulant - a drug that temporarily quickens some vital process
Translations

methylphenidate

n metilfenidato
References in periodicals archive ?
The settlement resolves allegations that Pfizer deceptively marketed its copayment coupon program for its Estring, Quillivant XR and Quillichew ER, and Flector Patch products when it distributed these copayment coupons to consumers throughout the state without clearly and conspicuously disclosing the material terms and conditions.
The agreement includes the acquisition of Quillivant XR, the extended-release oral liquid methylphenidate, and QuilliChew ER, the extended-release methylphenidate chewable tablet, both of which are central nervous system stimulants approved for the treatment of ADHD.
This acquisition includes Quillivant XR, the first and only marketed extended-release oral liquid methylphenidate as well as QuilliChew ER, the first and only extended-release methylphenidate chewable tablet, both of which are central nervous system (CNS) stimulants approved for the treatment of ADHD.
Drug Brand Generic Dosage Duration Name Form Form of Action AMP Salts Adderall XR Yes Capsule 8-12 h Dex-MPH Focalin XR No Capsule 6-10 h Dextro-AMP Dexedrine Yes Spansule 6-8 h Lisdexamfetamine Vyvanse No Capsule 10-12 h MPH Concerta Yes Tablet 10-12 h MPH Metadate CD Yes Capsule 8-10 h MPH Quillivant XR No Liquid 12 h MPH Ritalin LA Yes Capsule 8-10 h Drug Brand Crush/ Cost Name Sprinkle AMP Salts Adderall XR No/Yes $$ Dex-MPH Focalin XR No/Yes $$$$ Dextro-AMP Dexedrine No/Yes $ Lisdexamfetamine Vyvanse Yes/Yes $$$$ MPH Concerta No/No $$$ MPH Metadate CD No/Yes ss MPH Quillivant XR No/No $$$$ MPH Ritalin LA No/Yes $$
Pfizer now offers two different products for the treatment of ADHD in patients ages 6 years old and above liquid Quillivant XR(methylphenidate HCl) CII and new QuilliChew ER chewable tablets.CNS stimulants, including Quillivant XR, QuilliChew ER, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence.
NextWave is the developer of Quillivant XR (methylphenidate hydrochloride) for extended-release oral suspension, CII, the first once-daily liquid medication approved in the U.S.